
    
      The study is a multi-center, prospective, single-arm, and non-randomized study designed to
      evaluate the safety and performance of the CardiAQ-Edwardsâ„¢ Transcatheter Mitral Valve with
      transapical and transseptal delivery systems in patients with degenerative or
      functional/ischemic mitral regurgitation.
    
  